Quick Order |All Online Ordering|Product Catalog Ordering|Oligo Modifications List|Product Info & Literature|Oligo Design Tools/Resources

 Beta actin control PCR mix (human & Rat); 10 nmols
Catalog No. ProductPDF Guide Manual MSDS SizePrice.Quantity 
40-1002-10Beta actin control PCR mix (human & Rat); 10 nmols 10 nmols$131.00

ß-actin is ubiquitously expressed and serves as a positive control for northern, other expression studies and as controls for measuring cDNA synthesis efficiency by reverse transcription and as controls for mRNA (cDNA) quantitative expression studies. The human and Rat ß-actin PCR mix contains RT-PCRmerTM (Catalog Number 40-1001-10), PCR buffer and dNTP’s. It is ready to use by just adding template cDNA and Taq polymerase.

Related Products
beta actin D Human RT-PCRmer™ (F2/R2) Exon 4-3’ U; 10 nmols
beta actin G Human RT-PCRmer™ (F4/R1) Exon 2-3; 10 nmols
beta actin B Mouse RT-PCRmer (F2/R2) Exon 6-7; 10 nmols
beta actin F Human RT-PCRmer™ (F6/R2) 5’ UTR- 3’ ; 10 nmols
beta actin Human TaqMan Probe (F2/R3); Exon 5; 2 nmols
beta actin Human Molecular Beacon Probe (F2/R3B) Exon 5; 2 nmols
Human beta actin MB RT-PCRmer™ for Molecular Beacon assay (F2/R3B); Exon 4-5
beta actin Human RT-PCRmer™ for Taqman (F2/R3); 10 nmols
beta actin B Human RT-PCRmer™ (F4/R3B) Exon 2-5; 10 nmols
beta actin C Human RT-PCRmer™ (F6/R1) 5’UTR-Exon ; 10 nmols
GAPDH B Human RT-PCRmer™ (F2/R2) RT-PCRmer; 10 nmols
GAPDH C Human RT-PCRmer™ (F1/R2) Exon 2-7; 10 nmols
GAPDH D Human RT-PCRmer™ (F1/R3) Exon 2-9; 10 nmols
beta2 microglobulin Human RT-PCRmer ; 10 nmols
Beta actin control PCR mix (human & Rat); 10 nmols
beta actin A Human RT-PCRmer™ (F1/R1); Exon 3; 10 nmols
beta actin A Mouse RT-PCRmer™ (F1/R1) 3' Region; 10 nmols
GAPDH A Human/Mouse/RatRT-PCRmer™ (F1/R1) RT-PCRmer; 10 nmols
beta actin control PCR mix (human & Rat); 200 uL
Oligonucleotide Synthesis |  Flourescent Molecular Probes |  Gene Detection Systems |  Tools & Reagents |  Gene Assays |  RNAi
© 2017 Gene Link |  Terms & Conditions |  Licenses |  Privacy Policy |  March 24, 2017 5:08:24 AM